Well-known as one of the NFL’s greatest all-time running backs, Mike Haynes has been in the Pro Football Hall of Fame since 1997. Over his career he played for both the New England Patriots and the L.A. Raiders, and was known for his speed and agility.
Ronnie Lott was a hard-hitting cornerback who has had as much success off the field as he did on since his retirement. continue reading...
Men and women have different nutritional needs - therefore there are foods that are more important for each to eat. Here are a few, and why they’re important: continue reading...
Wine gets all the credit when it comes to health benefits. But research is increasingly showing that it’s not wine but, in fact, simply alcohol that thins your blood, reduces inflammation and improves sensitivity to insulin. So it’s a great time to be a beer lover! In case you need more reasons to chug, here are a few:
- A newly developed non-alcoholic beer may reduce hot flashes in menopausal women. (Hops contain low levels of the same plant estrogens found in soy.) continue reading...
According to a recent study, Bristish scientists have concluded that taller men are move vulnerable to to develop “rapidly progressive and aggresive prostate cancer.”
This conclusion was made because the same factors that influence height also contribute to increased risk of developing high-grade prostate cancer. continue reading...
Being screened for prostate cancer probably seems like a no-brainer to most health-conscious men, given that the disease is the second-most common cancer in American men as well as the second-most deadly, affecting one in six men.But earlier this week the U.S. Preventive Services Task Force, a panel of primary care experts that issues guidelines about clinical preventive services, recommended against routine prostate cancer screening for men over age 75. The group concluded there wasn’t proof that early detection was saving men’s lives and that the short-term harms outweighed the potential benefits. Read more…
According to Allison Van Dusen continue reading...
RARITAN, N.J., May 16 /PRNewswire/ — Veridex, LLC announced today that its licensing collaborator, Laboratory Corporation of America Holdings (LabCorp), has commercially launched a new gene methylation test for prostate cancer. The new assay uses the biological specificity of ‘DNA methylation’ in prostate cancer, detecting the methylation of the gene GST-Pi. Methylation is a modification of DNA that occurs primarily in cancer. Veridex is developing the methylation markers in this tissue assay, GST-Pi, along with other markers, for a urine-based screening test for prostate cancer.
Prostate cancer is the leading cause of cancer death in men in the U.S., with more than 230,000 cases diagnosed annually. continue reading...
DENVER, Sept. 13 /PRNewswire/ — Every three minutes a man finds out he has prostate cancer — the second-leading cause of cancer death in American men. In fact, more than 218,890 cases are expected in 2007, making prostate cancer among men more prevalent than breast cancer among women.
Yet men don’t get checked. That is why the non-profit Prostate Cancer Education Council (PCEC) coordinates free or low-cost screenings for millions of men across the United States each year during Prostate Cancer Awareness Week. The Council, which brings together recognized physicians and researchers, was founded on the fact that prostate cancer is nearly 100 percent survivable if caught in its earliest stages. continue reading...
Researchers have uncovered and are now able to track a key molecule that plays a role in the development and growth of prostate cancer. This ground-breaking discovery can very well cure the lives of many patients living with the disease.
“A molecule that plays a key role in prostate cancer development — and can predict recurrence — has been identified by researchers at the Mayo Clinic in Rochester, Minn. continue reading...
